All News
Pharma continues to drive Lonza growth
Andrew Warmington
PIC Regulation sees 22 substances added
Andrew Warmington
Digital intelligence: The chemical industry’s best counter to rising risk & uncertainty?
Andrew Warmington
Lanxess realigns in water treatment
Andrew Warmington
Azelis enters Israel with Orklia buy
Andrew Warmington
CEFIC calls for EU recovery plan
Andrew Warmington
CordenPharma in peptide expansion
Andrew Warmington
SOCMA report finds companies ‘bullish’
Andrew Warmington
Evotec initiates ‘Campus Curie’ in Toulouse
Andrew Warmington
ECHA: REACH driving substitution in many ways
Andrew Warmington
Covid-19: Four more events postponed
Andrew Warmington
Carlyle Group invests in Piramal
Andrew Warmington